• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Longevity Market
    Longevity News
    Longevity Stocks
    • Longevity Market
    • Longevity News
    • Longevity Stocks
    longevity investing

    Tivity Health Reports Fourth-Quarter 2017 Diluted EPS of $0.20 and Adjusted Diluted EPS of $0.41

    Gabrielle Lakusta
    Feb. 23, 2018 09:25AM PST
    Longevity Investing

    Tivity Health (NASDAQ:TVTY) announced financial results for the fourth quarter and year ended December 31, 2017. As quoted in the press release: Income from continuing operations was $8.6 million, a decrease of 28.9% from $12.1 million for the fourth quarter of 2016. Adjusted income from continuing operations increased 26.0% to $17.6 million compared to $14.0 million for the fourth quarter of 2016. The …

    Tivity Health (NASDAQ:TVTY) announced financial results for the fourth quarter and year ended December 31, 2017.

    As quoted in the press release:

    Income from continuing operations was $8.6 million, a decrease of 28.9% from $12.1 million for the fourth quarter of 2016. Adjusted income from continuing operations increased 26.0% to $17.6 million compared to $14.0 million for the fourth quarter of 2016. The fourth quarter of 2017 excludes $2.6 million in pre-tax restructuring charges and $7.4 million of income tax expense related to tax reform legislation. Adjusted income from continuing operations for the fourth quarter of 2016 excludes $5.2 million of pre-tax business separation costs and restructuring charges and a $2.2 million favorable adjustment to pre-tax depreciation expense. See pages 11-14 for a reconciliation of non-GAAP financial measures.

    Click here to read the full press release.

    financial resultslongevity investing
    The Conversation (0)

    Go Deeper

    AI Powered
    Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update

    Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update

    Goodness Growth Holdings Announces Fourth Quarter and Full Year 2023 Results

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Longevity Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×